Non-Small Cell Lung Cancer: Biomarker Testing Treatment Trends
Event Date
Tuesday, November 03, 2026
1:30 PM - 2:30 PM ET
Presented in Collaboration with:
- LUNGevity Foundation
- Lung Cancer Research Foundation
- Advanced Practitioner Society for Hematology and Oncology (APSHO)
- American Cancer Society
- American Psychosocial Oncology Society
- American Society of Clinical Oncology
- Association for Molecular Pathology
- Association of Clinicians for the Underserved
- Association of Oncology Social Work
- Black Womens Health Imperative
- Cancer Justice
- Cancer Nation
- Free ME from Lung Cancer
- GO2 for Lung Cancer
- Intercultural Cancer Council
- Joe's House
- The LGBT Cancer Project
- National Comprehensive Cancer Network (NCCN) NCCN Guidelines for Patients
- NeedyMeds
- Prevent Cancer Foundation
- Redes en Acción The National Latino Cancer Research Network
- Research Advocacy Network
- Scott Hamilton CARES Foundation
- Triage Cancer
- Vital Options International
This activity was made possible through an independent grant from Merck & Co., Inc., Bristol Myers Squibb and sponsored by Takeda Oncology. CancerCare’s application for continuing education credits for this program is supported by the Diana Napoli Fund.
Topics Covered
- Non-Small Cell Lung Cancer Overview
- Definition of Genomics and Biomarker Testing
- The Difference Between Genomics and Genetics
- The Role of Biomarker Testing in the Treatment of Non-Small Cell Lung Cancer
- Specific Examples of How Biomarker Testing May Inform Treatment Decisions
- Precision Medicine and Non-Small Cell Lung Cancer
- Current Research in Genomics and Non-Small Cell Lung Cancer
- Liquid Biopsies
- The Role of the Pathologist
- Reviewing Your Biomarker Testing with Your Health Care Team
- Key Questions to Ask Your Health Care Team About Biomarker Testing and Its Benefits for Your Treatment Choices
- Guidelines to Prepare for Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions, Follow-Up Care, and Discussion of OpenNotes
- Questions to Ask Our Panel of Experts
Speakers
Facilitator
Facilitator
Facilitator
Facilitator
Continuing Education Credits
Social Workers: This program has been submitted to the University of Texas MD Anderson Cancer Center, an approved provider through the Texas State Board of Social Work Examiners, provider #CS4607, for 1.0 Contact Hour.
Cancer Care, Inc. is recognized by the New York State Education Department’s State Board for Social Work as an approved provider of continuing education for licensed social workers #SW-0088. This workshop is approved for 1.0 Contact Hour.
Certified Health Education Specialists (CHES®): This program is designated for Certified Health Education Specialists (CHES®) and/or Master Certified Health Education Specialists (MCHES®) to receive up to 1 total Category I continuing education contact hour. Cancer Care, Inc is a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc.
To request continuing education paperwork, please email your name, profession, and address to [email protected] after the program. All paperwork for continuing education credit must be requested, completed, and submitted within two weeks of the live program.